B2B Central

Pharmaceutical manufacturing

08 Apr 2020

BASF produces and donates hand sanitiser to health care facilities in Europe

By Staff Writer

BASF Personal Care is producing and distributing hand sanitisers in Europe to assist with the COVID-19 outbreak on the continent. The company produces the hand sanitisers at different production sites in Europe. The products are being provided free of charge to hospitals, care facilities and other institutions in regions surrounding production plants. The company wants...
06 Apr 2020

Mondi adapts manufacturing plant to produce elastic straps for face masks

By Staff Writer

Mondi continues to produce important supplies and components during the COVID-19 outbreak. As a global leader in packaging and paper, Mondi’s Personal Care Components team has found a way to convert a production line at its Gronau plant in Germany to manufacture soft, elastic straps which are now being used for face masks and used...
01 Apr 2020

Virtual platforms get a boost in the pharma industry due to COVID-19 pandemic

By Staff Writer

The COVID-19 pandemic is having a transformational impact on the entire healthcare landscape as sales reps become more reliant on virtual platforms to meet with physicians. This according to data and analytics company GlobalData. Valentina Gburcik, PhD, senior director of Cardiovascular and Metabolic Diseases, Gender Health and Digital at GlobalData, comments: ‘The shift from in-person...
31 Mar 2020

SAHPRA urges South Africans to be wary of falsified health products

By Staff Writer

In the midst of the global COVID19 outbreak the South African Health Products Regulatory Authority (SAHPRA) urges the public not to buy medicines or medical devices from unauthorised vendors, websites or social media platforms. At a time of unprecedented demand for health products that can be used to prevent, diagnose or manage the novel coronavirus,...
31 Mar 2020

COVID-19 outbreak threatens biopharma in-house manufacturing

By Staff Writer

The novel coronavirus is complicating the global biopharma industry’s supply chain because several mega cap biopharma companies have their vital manufacturing steps in Chinese facilities. This is according to leading data and analytics company, GlobalData. Quarantined workforce Supply chain problems in China include a largely quarantined workforce, delays in transporting materials and several other logistical...
30 Mar 2020

Romaco Noack’s new blister packaging line impresses

By Staff Writer

Romaco Noack’s new Unity 600 blister packaging line is a high speed machine for medium to large batch sizes. Compact – carbon neutral – digital The Romaco Noack Unity 600 blister packaging line is a monobloc transfer solution that was specifically designed for blister formats arranged crosswise to the running direction. With a maximum output...
27 Mar 2020

Austell offers to donate COVID-19 treatment to SA Department of Health

By Staff Writer

Austell Pharmaceuticals has offered to supply the South African Department of Health with 500 000 tablets of Chloroquine Phosphate free of charge, which has shown to substantially reduce the infection and recovery time of patients with COVID-19. Austell is South Africa’s largest black-owned pharmaceutical company. The South African Health Products Regulatory Authority (SAHPRA) has given approval for...
23 Mar 2020

Good hair days are here to stay with Naturally Africa hair care

By Staff Writer

Naturally Africa aims to do away with bad hair days by treating your hair with the care and attention it deserves. The Naturally Africa team invested months in perfecting each product, ensuring that the range would protect, moisturise and nourish your hair and scalp – from root to tip. Clean beauty Each ingredient used in...
23 Mar 2020

I Holland is committed to the fight against COVID-19

By Staff Writer

I Holland has reassured customers that as a key supplier to the worldwide pharmaceutical industry it is 100 percent committed to doing everything within its power to support the fight against COVID-19. The company is very grateful to its colleagues in the global pharmaceutical industry for the work they are doing to support the treatment...
17 Mar 2020

Coronavirus outbreak has been a wakeup call for India’s pharma industry

By Staff Writer

According to GlobalData the global spread of Covid-19 has been a wakeup call to India’s pharma industry to reduce its dependence on China. The impact of the coronavirus (Covid-19) outbreak on industries ranging from technology to automotive has been the subject of intense analysis in the recent months. This has exposed dependence of India on...
17 Mar 2020

Cipla works closely with SAHPRA to bring quality medication to the public

By Staff Writer

CEO of Cipla South Africa, Paul Miller has met with the South African Health Products Regulatory Authority’s new CEO, Dr Boitumelo Semete-Makokotela about securing the necessary approvals for critical medication. Thanks to the efforts of SAHPRA with its Backlog clearance project which launched in August 2019, considerable progress has been made in terms of the...
13 Mar 2020

Cipla develops child-friendly treatment for children living with HIV

By Staff Writer

Cipla has prioritised the development of optimal child-friendly antiretroviral formulations for children living with HIV (CLHIV), specifically infants and young children at highest risk of dying without the access to treatment. Almost all parents can attest to the struggle experienced at mealtimes – think aeroplane noises and bribery – to get an infant or toddler...

Visit the official COVID-19 government website to stay informed: sacoronavirus.co.za